TABLE 2.
Subjects With Monitoring of Variable, n (%) |
Subjects With ≥ 1 Occurrence of a Transgression, n (%) |
||||||
---|---|---|---|---|---|---|---|
Transgression Variable | Progesterone (n = 442) | Placebo (n = 440) | Total (n = 882) | Progesterone (n = 442) | Placebo (n = 440) | Total (n = 882) | Subjects Not Monitored, n (%) |
Pao2 | 415 (93.9) | 410 (93.2) | 825 (93.5) | 257 (58.1) | 245 (55.7) | 502 (56.9) | 57 (6.5) |
Glucose (high) | 437 (98.9) | 437 (99.3) | 874 (99.1) | 219 (49.5) | 223 (50.7) | 442 (50.1) | 8 (0.9) |
Glucose (low) | 437 (98.9) | 437 (99.3) | 874 (99.1) | 88 (19.9) | 115 (26.1) | 203 (23.0) | 8 (0.9) |
Cerebral perfusion pressure | 242 (54.8) | 222 (50.5) | 464 (52.6) | 176 (39.8) | 176 (40.0) | 352 (39.9) | 418 (474) |
International normalized ratio | 404 (91.4) | 408 (92.7) | 812 (92.1) | 85 (19.2) | 84 (19.1) | 169 (19.2) | 70 (7.9) |
Platelets | 437 (98.9) | 437 (99.3) | 874 (99.1) | 25 (5.7) | 25 (5.7) | 50 (5.7) | 8 (0.9) |
O2 | 440 (99.5) | 440 (100.0) | 880 (99.8) | 160 (36.2) | 162 (36.8) | 322 (36.5) | 2 (0.2) |
Hemoglobin | 435 (98.4) | 438 (99.5) | 873 (99.0) | 165 (37.3) | 158 (35.9) | 323 (36.6) | 9 (1.0) |
Intracranial pressure | 238 (53.8) | 228 (51.8) | 466 (52.8) | 189 (4.8) | 167 (38.0) | 356 (40.4) | 416 (472) |
Mean arterial pressure | 435 (98.4) | 434 (98.6) | 869 (98.5) | 302 (68.3) | 318 (72.3) | 620 (70.3) | 13 (1.5) |
Brain tissue oxygen tension | 80 (18.1) | 75 (17.0) | 155 (17.6) | 29 (6.6) | 27 (6.1) | 56 (6.3) | 727 (82.4) |
SBP (high) | 441 (99.8) | 440 (100.0) | 881 (99.9) | 200 (45.2) | 206 (46.8) | 406 (46.0) | 1 (0.1) |
SBP (low) | 441 (99.8) | 440 (100.0) | 881 (99.9) | 216 (48.9) | 221 (50.2) | 437 (49.5) | 1 (0.1) |
Temperature (high) | 440 (99.5) | 440 (100.0) | 880 (99.8) | 311 (70.4) | 315 (71.6) | 626 (71.0) | 2 (0.2) |
Temperature (low) | 440 (99.5) | 440 (100.0) | 880 (99.8) | 161 (36.4) | 161 (36.6) | 322 (36.5) | 2 (0.2) |
SBP = systolic blood pressure.